Open access
Jul 2026
Real-world effectiveness and safety of protein-based and mRNA COVID-19 vaccines (BEEHIVE trial).
The results suggest that both protein-based and mRNA vaccines are well-tolerated and significantly reduce the risk of symptomatic SARS-CoV-2 infections.
Sarang K. Yoon, Andrew L. Phillips, S. Battan-Wraith et al.
· Vaccine · 1 citation